| pubmed-article:7532203 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7532203 | lifeskim:mentions | umls-concept:C0016030 | lld:lifeskim |
| pubmed-article:7532203 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:7532203 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:7532203 | lifeskim:mentions | umls-concept:C1149404 | lld:lifeskim |
| pubmed-article:7532203 | lifeskim:mentions | umls-concept:C1522240 | lld:lifeskim |
| pubmed-article:7532203 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:7532203 | pubmed:dateCreated | 1995-3-23 | lld:pubmed |
| pubmed-article:7532203 | pubmed:abstractText | Interferon-alpha/beta (IFN-alpha/beta) suppresses cell cycle activation by platelet-derived growth factor (PDGF) as well as the induction of the 31-kD (pI) and the 35-kD (pII) proteins in density-arrested BALB/c-3T3 cells. We report that elevation of [Ca2+]i by ionomycin induces the synthesis of the 31-kD protein, but not that of the 35-kD protein. Since IFN blocks the PDGF-induced elevation of [Ca2+]i, these results suggest that IFN treatment may suppress pI induction by impairing this PDGF-activated signal transduction pathway. In contrast, because ionomycin did not induce the 35-kD protein, the suppression by IFN of PDGF-induced pII appears to be mediated via a pathway distinct from that operating in the suppression of pI. In BALB/c-3T3 cells, IFN-alpha/beta did not itself affect the turnover or de novo synthesis of inositol phospholipids and the cellular content of diacylglycerol, nor did IFN block the enhancement of these parameters by PDGF. | lld:pubmed |
| pubmed-article:7532203 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7532203 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7532203 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7532203 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7532203 | pubmed:issn | 0197-8357 | lld:pubmed |
| pubmed-article:7532203 | pubmed:author | pubmed-author:PledgerW JWJ | lld:pubmed |
| pubmed-article:7532203 | pubmed:author | pubmed-author:TammII | lld:pubmed |
| pubmed-article:7532203 | pubmed:author | pubmed-author:KikuchiTT | lld:pubmed |
| pubmed-article:7532203 | pubmed:author | pubmed-author:PfefferL MLM | lld:pubmed |
| pubmed-article:7532203 | pubmed:author | pubmed-author:KreutterDD | lld:pubmed |
| pubmed-article:7532203 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7532203 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:7532203 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7532203 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7532203 | pubmed:pagination | 265-73 | lld:pubmed |
| pubmed-article:7532203 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:meshHeading | pubmed-meshheading:7532203-... | lld:pubmed |
| pubmed-article:7532203 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7532203 | pubmed:articleTitle | Selective interferon-alpha/beta effects on platelet-derived growth factor-stimulated processes in quiescent BALB/c-3T3 fibroblasts. | lld:pubmed |
| pubmed-article:7532203 | pubmed:affiliation | Rockefeller University, New York, NY 10021. | lld:pubmed |
| pubmed-article:7532203 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7532203 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7532203 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7532203 | lld:pubmed |
